Open access · CC-BY
via OpenAlex
Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Emanuel J. Novais, Victoria A. Tran, Shira N. Johnston, Kayla R. Darris, Alex Roupas, Garrett A. Sessions, Irving M. Shapiro, Brian O. Diekman, Makarand V. Risbud
Nature Communications · 2021 · ▲ 440 citations
Abstract
Abstract Intervertebral disc degeneration is highly prevalent within the elderly population and is a leading cause of chronic back pain and disability. Due to the link between disc degeneration and senescence(definition), we explored the ability of the Dasatinib and Quercetin drug combination (D + Q) to prevent an age-dependent progression of disc degeneration in mice. We treated C57BL/6 mice beginning at 6, 14, and 18 months of age, and analyzed them at 23 months of age. Interestingly, 6- and 14-month D + Q cohorts showed lower incidences of degeneration, and the treatment resulted in a significant decrease in senescent markers p16INK4a, p19ARF, and SASP molecules IL-1β, and IL-6. Treated animals also showed preserved cell viability, phenotype, and matrix content. Although transcriptomic analysis showed disc compartment-specific effects of the treatment, cell death and cytokine response pathways were commonly modulated across tissue types. Results suggest that senolytics(definition) may provide a novel approach to mitigating age-dependent disc degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41467-021-25453-2
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Novais, E.J., Tran, V.A., Johnston, S.N., Darris, K.R., Roupas, A., Sessions, G.A., Shapiro, I.M., Diekman, B.O., & Risbud, M.V. (2021). Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-021-25453-2
Vancouver
Novais EJ, Tran VA, Johnston SN, Darris KR, Roupas A, Sessions GA, et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nature Communications. 2021. doi:10.1038/s41467-021-25453-2.
BibTeX
@article{emanuel2021Longte,
title = {Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice},
author = {Emanuel J. Novais and Victoria A. Tran and Shira N. Johnston and Kayla R. Darris and Alex Roupas and Garrett A. Sessions and Irving M. Shapiro and Brian O. Diekman and Makarand V. Risbud},
journal = {Nature Communications},
year = {2021},
doi = {10.1038/s41467-021-25453-2},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2021
Preprint · CC-BY
Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Bone Research 2026
Open access · CC-BY
Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice
Research Square 2025
Preprint · CC-BY
Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice
Aging 2020
Preprint · CC-BY
Influences of circulatory factors on intervertebral disc aging phenotype
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · CC-BY
Sexual Dimorphic Metabolic and Cognitive Responses of C57BL/6 Mice to Fisetin or Dasatinib and Quercetin Cocktail Oral Treatment
Biomedicine & Pharmacotherapy 2020
Open access · CC-BY